Prevalence and Predictors of Left Ventricular Diastolic Dysfunction in a Hispanic Patient Population

Abstract

Minimal data exist on attributes of diastolic dysfunction in the Hispanic population. The purpose of this study was to evaluate the prevalence and predictors of diastolic dysfunction in a Hispanic patient population. We performed a retrospective review of 166 consecutive echocardiograms in a southwestern Texas Hospital that caters to a large Hispanic patient population. We identified all echocardiograms that met criteria for diastolic dysfunction and assessed baseline demographics and comorbidities in the cohort of Hispanic patients. A multivariate analysis was performed to identify the independent predictors of diastolic dysfunction. A total of 129 out of 166 patients (77.8%) were of Hispanic origin. Out of the 129 patients, 87 (67.4%) had some degree of diastolic dysfunction in this population suggesting a high prevalence in the study cohort. In the diastolic dysfunction group, the mean age was 64.5 ± 13.9, 37% were male and 63% female, 78% had diabetes, 85% had hypertension, and 49% had some degree of renal insufficiency (stages 3–5). A logistic multivariate analysis showed that diabetes was an independent predictor of diastolic dysfunction with odds ratio of 2.69 (95% confidence interval [CI], 1.06–6.28; p = 0.038). Similarly age (per year increase) and chronic kidney disease were independent predictors of diastolic dysfunction. We demonstrated that older age, presence of diabetes, and renal dysfunction are independent predictors of diastolic dysfunction in the Hispanic patient population. Strategies geared toward reducing diabetes and preventing renal dysfunction are likely to decrease prevalence of diastolic dysfunction and heart failure in this community.

Keywords

left ventricular dysfunction - diabetes complications - Hispanic patient population - prevalence

• References

• 1 Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med 2004; 351 (11) 1097-1105
• 2 Bin-Jaliah I, Ammar HI, Mikhailidis DP , et al. Cardiac adaptive responses after hypoxia in an experimental model. Angiology 2010; 61 (2) 145-156
• 3 Zile MR, Wexler L, Gaasch WH. Pathophysiology of diastolic heart failure. Available at: http://www.uptodate.com/contents/pathophysiology-of-diastolic-heart-failure
• 4 Andersson C, Gislason GH, Weeke P , et al. Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovasc Diabetol 2010; 9: 3
• 5 Liu JE, Palmieri V, Roman MJ , et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 2001; 37 (7) 1943-1949
• 6 Störk T, Möckel M, Danne O, Völler H, Eichstädt H, Frei U. Left ventricular hypertrophy and diastolic dysfunction: their relation to coronary heart disease. Cardiovasc Drugs Ther 1995; 9 (Suppl. 03) 533-537
• 7 Kuznetsova T, Herbots L, López B , et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2009; 2 (2) 105-112
• 8 Fischer M, Baessler A, Hense HW , et al. Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24 (4) 320-328
• 9 Kane GC, Karon BL, Mahoney DW , et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 2011; 306 (8) 856-863
• 10 Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33 (7) 1948-1955
• 11 Luchner A, Bröckel U, Muscholl M , et al. Gender-specific differences of cardiac remodeling in subjects with left ventricular dysfunction: a population-based study. Cardiovasc Res 2002; 53 (3) 720-727
• 12 Jarnert C, Landstedt-Hallin L, Malmberg K , et al. A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: a report from the DADD (Diabetes mellitus And Diastolic Dysfunction) study. Eur J Heart Fail 2009; 11 (1) 39-47
• 13 Poulsen MK, Henriksen JE, Dahl J , et al. Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging 2010; 3 (1) 24-31
• 14 National Diabetes Information Clearinghouse (NDIC). National Diabetes Statistics, 201. Available at: http://diabetes.niddk.nih.gov/index.aspx
• 15 von Bibra H, Hansen A, Dounis V, Bystedt T, Malmberg K, Rydén L. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart 2004; 90 (12) 1483-1484
• 16 Moutzouri E, Florentin M, Elisaf MS, Mikhailidis DP, Liberopoulos EN. Aliskiren, a direct renin inhibitor, in clinical practice: a new approach in the treatment of hypertension. Curr Vasc Pharmacol 2010; 8 (3) 344-362